D Pharm (Israel) Buy Hold or Sell Recommendation

    DPRM -- Israel Stock  

    ILS 430.00  0.60  0.14%

    Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding D Pharm LTD is 'Not Rated'. Macroaxis provides D Pharm buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding D Pharm positions. The advice algorithm takes into account all of D Pharm LTD available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from D Pharm buy-and-hold prospective. Additionally see Investing Opportunities.

    Time Horizon

    Risk Tolerance

    Execute Advice
    Sell D PharmBuy D Pharm
    Not Rated
    For the selected time horizon D Pharm LTD has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
    Macroaxis provides buy, hold, or sell suggestion on D Pharm LTD to complement and cross-verify current analyst consensus on D Pharm LTD. Our buy, hold, or sell recommendation engine determines the company potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure D Pharm is not overpriced, please confirm all D Pharm LTD fundamentals including its Revenue, EBITDA, Cash and Equivalents, as well as the relationship between Gross Profit and Net Income .

    D Pharm Trading Alerts and Improvement Suggestions

    D Pharm LTD is not yet fully synchronised with the market data
    The company reported revenue of 723K. Net Loss for the year was (814K) with profit before overhead, payroll, taxes, and interest of 723K.
    D-PHARM has accumulated about 314K in cash with (313K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
    Search macroaxis.com